Insider · CIK 0001164426
Joseph Edelman
directorowner
Files at LYRA (Lyra Therapeutics, Inc.), ALDX (Aldeyra Therapeutics, Inc.), LONA (Athira Pharma, Inc.), SLDB (Solid Biosciences Inc.), MGTX (MeiraGTx Holdings plc), ACRV (Acrivon Therapeutics, Inc.), OBIO (Orchestra BioMed Holdings, Inc.), ADGM (Adagio Medical Holdings, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | LONA Athira Pharma, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,900 | $0.00 | $0 | 20,900 | Jun 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.